Advertisement
Protagonist Therapeutics, Inc. (PTGX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 47.61 |
| Open | 48.86 |
| Bid | 46.09 x 200 |
| Ask | 46.33 x 100 |
| Day's Range | 45.26 - 48.86 |
| 52 Week Range | 15.05 - 48.89 |
| Volume | |
| Avg. Volume | 600,758 |
| Market Cap | 2.804B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 17.51 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Tops Revenue Estimates
Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of 8.47% and 3.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press Finance
Protagonist Therapeutics: Q3 Earnings Snapshot
NEWARK, Calif. AP) — Protagonist Therapeutics Inc. PTGX) on Thursday reported a loss of $33.2 million in its third quarter.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.